Position in INSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$363,072,019
-$142,663,780 QoQ
Shares Held
3,405,290
+10.1% QoQ
Ownership
1.56%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#16
of 665 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. INSM ranks #9 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in INSM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $363,072,019 | 3,405,290 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $505,735,799 | 3,092,807 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $703,028,661 | 4,039,466 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $998,200,417 | 6,931,466 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,130,258,150 | 11,230,705 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $985,936,942 | 12,923,541 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $877,112,465 | 12,704,410 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $918,411,613 | 12,580,981 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $814,945,656 | 12,163,368 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $292,172,899 | 10,769,366 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $333,569,262 | 10,763,771 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $262,782,203 | 10,407,216 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $214,635,444 | 10,172,296 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $170,194,191 | 9,982,064 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $199,358,661 | 9,977,911 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $205,669,240 | 9,548,247 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $319,910,125 | 16,222,623 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $372,669,133 | 15,858,261 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $417,349,596 | 15,321,204 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $405,951,497 | 14,740,432 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $409,046,615 | 14,372,685 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $384,964,682 | 11,302,545 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $321,325,200 | 9,652,304 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $305,305,895 | 9,499,250 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $263,483,414 | 9,567,299 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $111,831,836 | 6,976,409 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||